Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis

Frontiers in Medicine

Daniela Ferreira Barreira¹  Rita Adubeiro Lourenço¹  Paula Alexandra Videira²  Lúcio Lara Santos³  Rita Calisto⁴  Daniel Moreira-Gonçalves⁵ 

[1] Department of Life Sciences, Applied Molecular Biosciences Unit, Faculdade de Ciências e Tecnologia da Universidade Nova De Lisboa, Caparica, Portugal;Department of Life Sciences, Applied Molecular Biosciences Unit, Faculdade de Ciências e Tecnologia da Universidade Nova De Lisboa, Caparica, Portugal;Congenital Disorders of Glycosylation Professionals and Patient Associations International Network (CDG and Allies-PPAIN), Lisboa, Portugal;Experimental Pathology and Therapeutics Group, Research Center, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal;Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal;Portuguese Institute of Oncology Francisco Gentil, Porto, Portugal;Cancer Epidemiology Group, Portuguese Institute of Oncology Porto Research Centre (CI-IPOP), Portuguese Institute of Oncology Francisco Gentil, Porto, Portugal;Research Centre in Physical Activity, Health and Leisure, Faculdade de Desporto, Universidade do Porto, Porto, Portugal;

关键词: COVID-19;    convalescent plasma;    meta-analysis;    mortality;    safety;    viral clearance;    clinical trials;   

DOI  :  10.3389/fmed.2021.660688

来源: Frontiers

【 授权许可】

CC BY